Ironwood Pharmaceuticals IRWD Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Ironwood Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's cash ratio?
- Ironwood Pharmaceuticals (IRWD) reported cash ratio of 0.9× in Q1 2026.
- How has Ironwood Pharmaceuticals's cash ratio changed year-over-year?
- Ironwood Pharmaceuticals's cash ratio decreased by 58.6% year-over-year, from 2.3× to 0.9×.
- What is the long-term trend for Ironwood Pharmaceuticals's cash ratio?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's cash ratio has grown at a -39.8% compound annual growth rate (CAGR), from 11.3× to 0.9×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.